MARCUCCI, GEMMA
 Distribuzione geografica
Continente #
NA - Nord America 3.208
EU - Europa 1.928
AS - Asia 491
SA - Sud America 3
AF - Africa 1
OC - Oceania 1
Totale 5.632
Nazione #
US - Stati Uniti d'America 3.197
PL - Polonia 703
IT - Italia 423
IE - Irlanda 307
SE - Svezia 269
HK - Hong Kong 223
CN - Cina 116
SG - Singapore 47
RU - Federazione Russa 43
FI - Finlandia 42
GB - Regno Unito 39
JO - Giordania 34
IN - India 30
BE - Belgio 29
DE - Germania 22
VN - Vietnam 19
FR - Francia 18
TR - Turchia 12
CA - Canada 10
UA - Ucraina 10
CH - Svizzera 7
ES - Italia 6
KR - Corea 5
AT - Austria 4
RO - Romania 3
CL - Cile 2
IR - Iran 2
NL - Olanda 2
AR - Argentina 1
AU - Australia 1
GE - Georgia 1
GT - Guatemala 1
MU - Mauritius 1
MY - Malesia 1
PT - Portogallo 1
TH - Thailandia 1
Totale 5.632
Città #
Warsaw 702
Fairfield 476
Chandler 341
Dublin 306
Ashburn 287
Woodbridge 224
Houston 218
Seattle 205
Ann Arbor 181
Cambridge 175
Wilmington 157
Hong Kong 154
Lawrence 101
Altamura 99
Princeton 93
Florence 62
Boston 61
Beijing 58
Medford 37
Shanghai 35
Boardman 32
Buffalo 30
Singapore 30
Brussels 28
New York 26
Pune 26
San Diego 22
Kent 18
Norwalk 17
Jacksonville 16
Dong Ket 14
Falls Church 13
Hillsboro 10
Andover 9
Izmir 9
Moscow 9
Toronto 9
Duncan 8
Somerville 8
Phoenix 7
Barcelona 6
Guangzhou 6
Milan 6
Siena 6
Bern 5
Cagliari 5
Redwood City 5
Cesena 4
London 4
Pisa 4
Poggio A Caiano 4
Salerno 4
West Jordan 4
Anguillara Sabazia 3
Laurel 3
Munich 3
Redmond 3
Rome 3
Saint Petersburg 3
Barberino Di Mugello 2
Castelliri 2
Cedar Knolls 2
Dearborn 2
Grosseto 2
Las Condes 2
Livorno 2
Menlo Park 2
Perugia 2
Roccastrada 2
Seoul 2
Wuhan 2
Acton 1
Alessandria 1
Angera 1
Augusta 1
Baltimore 1
Bari 1
Brooklyn 1
Busto Arsizio 1
Calcinaia 1
Chennai 1
Colle Di Val D'elsa 1
Collecorvino 1
Cork 1
Dallas 1
Domusnovas 1
Empoli 1
Ereiras 1
Ferlach 1
Ferrara 1
Groningen 1
Guatemala City 1
Hanoi 1
Hounslow 1
Isfahan 1
Jinan 1
Kuala Lumpur 1
Kunming 1
Kutaisi 1
Leawood 1
Totale 4.447
Nome #
Estrogen inhibits starvation-induced apoptosis in osteocytes by a redox-independent process involving association of JNK and glutathione S-transferase P1-1 233
Protective role of benzoselenophene derivatives of resveratrol on the induced oxidative stress in intestinal myofibroblasts and osteocytes 203
Oxidative stress in bone remodeling: role of antioxidants 186
Clinical presentation and management of hypoparathyroidism. 173
Phosphate wasting disorders in adults. 173
Clinical guidelines for the prevention and treatment of osteoporosis: summary statements and recommendations from the Italian Society for Orthopaedics and Traumatology 165
Causes and pathophysiology of hypoparathyroidism 162
Calcium Intake in Bone Health: A Focus on Calcium-Rich Mineral Waters 161
HypoparaNet: A Database of Chronic Hypoparathyroidism Based on Expert Medical-Surgical Centers in Italy 122
Rare diseases in clinical endocrinology: a taxonomic classification system. 115
Redox regulation of ERK1/2 activation induced by sphingosine 1-phosphate in fibroblasts: involvement of NADPH oxidase and platelet-derived growth factor receptor. 108
Is calcium signaling relevant for long bone growth? 102
Cystic bone angiomatosis: a case report treated with aminobisphosphonates and review of the literature 101
Gaucher Disease and Bone Manifestations. 99
Prevalence of Chronic Hypoparathyroidism in a Mediterranean Region as Estimated by the Analysis of Anonymous Healthcare Database 98
Blueberry juice protects osteocytes and bone precursor cells against oxidative stress partly through SIRT1 97
Bone health in childhood cancer: review of the literature and recommendations for the management of bone health in childhood cancer survivors 94
Glutathione, N-acetylcysteine and Lipoic Acid Down-Regulate Starvation-Induced Apoptosis, RANKL/OPG Ratio and Sclerostin in Osteocytes: Involvement of JNK and ERK1/2 Signalling. 93
Incidence and costs of hip fractures vs strokes and acute myocardial infarction in Italy: comparative analysis based on national hospitalization records. 86
A novel recessive mutation of fibroblast growth factor-23 in tumoral calcinosis 86
Osteoporosi con fratture in gravidanza e allattamento 86
Human Preosteoblastic Cell Culture from a Patient with Severe Tumoral Calcinosis-Hyperphosphatemia Due to a New GALNT3 Gene Mutation: Study of In Vitro Mineralization. 85
Osteonecrosis of the Jaw In A Patient With Rheumatoid Artritis Treated With An Oral Aminobisphosphonate: A Clinical Case Report 79
Natpara for the treatment of hypoparathyroidism 78
Drug safety evaluation of parathyroid hormone for hypocalcemia in patients with hypoparathyroidism. 76
Calcolosi renale recidivante: una nnuova mutazione del gene codificante il recettore del calcio( CASR) 75
The T.A.R.Ge.T. project: a regional program to reduce hip fracture in elderly patients. Main results of retrospective phase. 72
Osteonecrosis of the jaw in a patient with rheumatoid artritis treated with an oral aminobisphosphonate: a clinical case report. 69
Conventional Treatment of Hypoparathyroidism 69
Molecular diagnosis of parathyroid carcinoma: a reality in the near future. 69
Mutations in GALNT3 GENE: Two adolescents with tumoral calcinosis-hyperphosphatemia 69
Rare causes of osteoporosis. 69
Osteoporotic patient course after surgical treatment with hip prosthesis 66
Blueberry juice antioxidants protect osteogenic activity against oxidative stress and improve long-term activation of the mineralization process in human osteoblast-like saos-2 cells: Involvement of sirt1 66
Osteoporotic vertebral compression fractures: conservative or surgical treatment? 64
Refractory Hypoparathyroidism and treatment with recombinant human PTH [rhPTH 1-34: Teriparatide] 63
CYP19 and ESR1 gene polymorphisms: response of the bone mineral density in post-menopausal women to hormonal replacement therapy 61
A New Era for Chronic Management of Hypoparathyroidism: Parathyroid Hormone Peptides 60
Role of glutathione on growth and osteogenic activity in osteoblasts 60
Variazioni molecolari del gene codificante la fosfatasi alcalina: correlazione con la massa ossea (BMD) e i markers biochimici di turnover osseo 59
Role of GSH/GSSG redox couple in osteogenic activity and osteoclastogenic markers of human osteoblast-like SaOS-2 cells. 57
Hypoparathyroidism and treatment with recombinant human PTH 56
Soft tissue postraumatic calcifications associated with a new FGF23 gene mutation: clinicopathological and molecular genetic study 52
Phosphatonins: New hormones that control phosphorus homeostasis 51
A New Fgf23 Gene Polymorphism: Possible Role In the Pathogenesis of the Development of Extraskeletal Calcifications? 50
Osteoporosi e frattura del femore in gravidanza 49
THE EFFECTS OF RH-PTH (1-34) ON BONE METABOLISM IN HYPOPARATHYROID PATIENTS 49
Compliance to antifracture treatments in Tuscany: a regional survey based on institutional pharmaceutical dataset. 48
Intracellular oxidative status and glutathione role on osteogenic activity of osteoblastic cells 48
PAMIDRONATE TREATMENT IN A PATIENT WITH FIBROUS DYSPLASIA OF THE JAW AND FGF-23 MUTATION 48
Pharmacogenetics of bone treatments: the VDR and ERalpha gene story. 47
Role of glutathione and oxidative state on marker genes involved in bone remodelling 47
Un nuovo caso di sclerosi ossea: osteopochilosi 44
PRIMARY CULTURES OF HUMAN SKELETAL MUSCLE SATELLITE CELLS: A NOVEL MODEL TO ASSESS SKELETAL MUSCLE CELL DIFFERENTIATION 44
Effect of Oxidative Stress-Induced Apoptosis on Active FGF23 Levels in MLO-Y4 Cells: The Protective Role of 17-β-Estradiol 43
A NOVEL MUTATION OF TGF-1 IN CAMURATI-ENGELMANN DISEASE: GENOTYPE-PHENOTYPE CORRELATION AND MEDICAL MANAGEMENT 41
Glutathione role on proliferation and differentiation processes of osteoblastic cells 40
Cosegregation of cardiovascular diseases and osteoporosis: Instrumental diagnosis 40
CALCIFICATIONS IN DERMATOMYOSITIS: A CLINICAL CASE WITH AN ALTERATION OF PHOSPHATE HOMEOSTASIS, CARRIER OF A NEW FGF23 GENE MUTATION 40
BONE FIBROUS DYSPLASIA: A RETROSPECTIVE REVIEW OF 34 CASES 39
Mutations In Galnt3 Gene: Two Cases of Tumoral Calcinosis-hyperphosphatemia 39
Osteogenesis Imperfecta: Realization of A Multidisciplinar Network To Improve Information, Expertise and Resources 38
Molecular genetic analysis in the diagnosis of humoral calcinosis 37
A NOVEL TISSUE-NONSPECIFIC ISOENZYME OF ALKALINE PHOSPHATASE (TNSALP) MUTATION IN ADULT PATIENT WITH LOW BONE MASS AND MUSCULOSKELETAL SYMPTOMS 36
Chronic hypoparathyroidism and treatment with teriparatide 36
Tricho-rhino-phalangeal syndrome: role of different methods of measuring bone density 35
ALPL genotypes in patients with atypical femur fractures or other biochemical and clinical signs of hypophosphatasia 35
Hypoparathyroidism and pseudohypoparathyroidism in pregnancy: an Italian retrospective observational study 35
Biological effects of various regimes of 25-hydroxyvitamin D3 (calcidiol) administration on bone mineral metabolism in postmenopausal women 34
In vitro non-genomic effects of calcifediol on human preosteoblastic cells 33
Glutathione role on specific markers of the bone remodeling 32
Role of GSH and estrogen on serum-starvation induced apoptosis in osteocytes 30
Congenital Conditions of Hypophosphatemia Expressed in Adults 30
Persistence long-term of alendronate therapy on osteoporotic population in Tuscany region 29
Estrogens down-regulate RANKL/OPG ratio and sclerostin levels in starvation-induced apoptosis in osteocytes. 29
Skeletal and extraskeletal disorders of biomineralization 27
A case of multi centric giant cell tumors with 25-year follow up 27
Role of antioxidants on RANKL and OPG production in apoptotic osteocytes 26
Oxidative Stress and Natural Antioxidants in Osteoporosis: Novel Preventive and Therapeutic Approaches. 25
Genetics of Osteoporosis 24
Redox regulation of osteogenic activity in osteoblastic cells 21
Vertebroplasty and balloon kyphoplasty in osteoporosis: Friends or foes? 20
RETROSPECTIVE COHORT STUDY OF PATIENTS AFFECTED BY CHRONIC HYPOPARATHYROIDISM 19
Kyphoplasty and vertebroplasty in the management of osteoporosis with subsequent vertebral compression fractures 18
Polymorphic variants of alkaline phosphatase gene correlate with clinical signs of adult hypophosphatasia? 14
Role of glutathione and oxidative state on markers genes involved in bone remodelling 12
Multicenter retro-prospective observational study on chronic hypoparathyroidism and rhPTH (1-84) treatment 9
Totale 5.735
Categoria #
all - tutte 17.873
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.873


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.265 90 91 39 91 168 139 126 144 125 93 114 45
2020/2021866 77 74 42 95 46 76 32 105 77 139 61 42
2021/2022587 11 75 27 38 29 21 17 47 65 17 68 172
2022/20231.462 147 325 69 86 95 261 175 84 149 8 49 14
2023/2024623 31 53 87 48 29 96 18 198 4 15 27 17
2024/202568 68 0 0 0 0 0 0 0 0 0 0 0
Totale 5.735